Senti Biosciences is trading 6.98% up at $0.46 in pre-market ahead of its virtual annual shareholder meeting today, August 18, 2026, which includes a proposed merger vote with a Celadon affiliate. - The company is also expected to announce its Q2 2026 results today, August 18, 2026. - Recent Q2 reports from August 14, 2026, already highlighted continued liquidity concerns and the planned merger and corporate actions including votes on stock issuance, director elections, and a potential reverse stock split.